Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cabergoline vs Norethindrone for Endometriosis Pain
NCT02542410Phase 2Completed
- Sponsor
- Boston Children's Hospital
- Start
- May 2016
- Primary completion
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cabergoline in endometriosis (2 arms), sponsored by Boston Children's Hospital. Primary endpoint: Change in Score in Worst Pain Over the Last Month at 6 months. Started May 2016; status: completed.
02
Drugs
cabergoline
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT02542410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02542410.